카바페넴 내성 Enterobacterales에서carbapenemase의 신속 검출 및 형별 분류를 위한두 가지 상용화된 제품의 평가
Evaluation of Two Commercial Kits for Rapid Detection and Typing of Carbapenemase in Carbapenem-Resistant Enterobacterales
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
배경: Carbapenemase 생성 Enterobacterales (CPE)를 신속하게 검출하는 것은 적절한 항균제 선택과 감염관리에 있어서 중요하다. KPC, NDM, VIM, IMP, OXA-48 계열 carbapenemase 검출능을 평가하기 위하여 다중 lateral flow immunoassay 기법을 사용하는 NG-Test Carba5 (Carba5; NGBiotech, France)와 전자동 실시간 PCR 기법을 사용하는 BD MAX Check-Points CPO Assay (CPO;BD Diagnostic Systems, USA) 등 2가지 검사법을 수기 PCR을 이용한 유전자형 분석과 비교평가하였다. 방법: 2013년부터 2019년까지 서울아산병원에서 분리된 카바페냄 내성Enterobacterales (CRE) 중가급적 carbapenemase 형별 당 20주 이상, carbapenemase 음성인 CRE는 60주 정도를 연구대상에포함하고자 하였다. Carbapenemase 유전자형 분석을 위해 KPC, NDM, OXA-48 계열의 경우 단독PCR을 시행하였고, VIM, IMP, GIM, SIM, SPM은 다중 PCR을 시행하였다. 모든 분리주는 Carba5와 CPO로 검사하였다. 유전자형 검사 결과가 불일치할 경우 단일 목표 유전자에 특이적인 수기PCR과 GeneXpert Carba-R Assay (Carba-R; Cepheid, USA)를추가로시행하였다. 결과: 총 147주의 CRE를 평가하였고 82주(55.8%)의 CPE를 포함하였다. CPE는 KPC 20주,NDM 22주, VIM 17주, IMP 3주, OXA-48계열 13주, 두 종류의 carbapenemase 양성인 7주(KPC/VIM 3주, NDM/VIM 2주, KPC/NDM 1주, NDM/OXA-48-계열 1주)로 구성되었다. Carba5와CPO는 모든 CPE를 정확하게 검출하였으며, 2주의 IMP 양성 CPE가 추가로 검출되었다. Carba5와 CPO의 민감도와 특이도는 둘 다 각각 100%, 97%로 동일하였다. IMP 위양성인 2주는Carba-R과 IMP-특이적인단일유전자 PCR에서 IMP 양성임을확인하였다. 결론: Carba5와 CPO는 배양된 집락으로부터 다섯 가지 주요 carbapenemase를 정확하게 검출하고형별을 분류할 수 있었다. Carba5는 더 신속하고 간편하여 임상검사실에서 즉석검사로 사용할 수있다는장점이있다.
Abstract
Background: Rapid detection of carbapenemase-producing Enterobacterales (CPE) isdesirable to guide antimicrobial therapy and infection control. The NG-Test Carba5 (Carba5;NG Biotech, France) rapid multiplex lateral flow immunoassay and BD MAX Check-Points CPOAssay (CPO; BD Diagnostic Systems, USA) fully automated real-time PCR assay were evaluatedfor the detection of KPC, NDM, VIM, IMP, and OXA-48-like group in a culture colony comparedto genotyping using conventional PCR. Methods: Among the clinical isolates of carbapenem-resistant Enterobacterales(CRE) collected from 2013 to 2019, up to 20 isolates for each carbapenemase type,and approximately 60 carbapenemase-negative CRE were enrolled. Genotyping ofcarbapenemases were performed using single-target PCR for KPC, NDM, and OXA-48-likegroup and the multiplex PCR for VIM, IMP, GIM, SIM, and SPM. All isolates were tested withCarba5 and CPO. The discrepant results were resolved by single-target specific conventionalPCR or GeneXpert Carba-R Assay (Carba-R; Cepheid, USA). Results: Of 147 CREs, 82 were CPE (55.8%) including 20 KPC, 22 NDM, 17 VIM, three IMP, and13 OXA-48-like group, and seven double carbapenemase-positive (three KPC/VIM, two NDM/VIM, one KPC/NDM, and one NDM/OXA-48-like group) isolates. Carba5 and CPO detected allCPE correctly along with two more IMP-producing CPE. The sensitivity and specificity of bothkits were equally 100% and 97%. Two false IMP-positives were confirmed IMP-positive withCarba-R and IMP-specific single-target PCR. Conclusion: Carba5 and CPO reliably detect and differentiate five common carbapenemasesin cultured colonies. Carba5, faster and simpler, is preferred as a spot test.
참고문헌 (28)
- Papp-Wallace KM, "Carbapenems: past, present, and future", Antimicrob Agents Chemother, 55, pp.4943~4960 (2011)
- Zilberberg MD, "Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis", BMC Infect Dis, 17, pp.279~ (2017)
- Friedman ND, "Carbapenem-resistant Enterobacteriaceae : a strategic roadmap for infection control", Infect Control Hosp Epidemiol, 38, pp.580~594 (2017)
- Baeza LL, "Comparison of five methods for detection of carbapenemases in Enterobacterales with proposal of a new algorithm", Clin Microbiol Infect, 25, pp.1286e9~1286e15 (2019)
- Sheppard AE, "Nested Russian doll-like genetic mobility drives rapid dissemination of the carbapenem resistance gene blaKPC", Antimicrob Agents Chemother, 60, pp.3767~3778 (2016)
- Tamma PD, "Phenotypic detection of carbapenemase-producing organisms from clinical isolates", J Clin Microbiol, 56, pp.e01140~18 (2018)
- Moore NM, "Rapid identification of five classes of carbapenem resistance genes directly from rectal swabs by use of the Xpert Carba-R assay", J Clin Microbiol, 55, pp.2268~2275 (2017)
- Girlich D, "Evaluation of the BD MAX Check-Points CPO assay for the detection of carbapenemase producers directly from rectal swabs", J Mol Diagn, 22, pp.294~300 (2020)
- Boutal H, "Development and validation of a lateral flow immunoassay for rapid detection of NDM-producing Enterobacteriaceae", J Clin Microbiol, 55, pp.2018~2029 (2017)
- Boutal H, "A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae", J Antimicrob Chemother, 73, pp.909~915 (2018)
- Performance standards for antimicrobial susceptibility testing, "Clinical and Laboratory Standards Institute (CLSI)", CLSI, ~, pp.CLSI M100-S26 (2017)
- A guideline for diagnosing carbapenemase-producing Enterobacteriaceae, "Korean disease control center", Korean disease control center, ~ (2017)
- Chen L, "Multiplex realtime PCR for detection of an epidemic KPC-producing Klebsiella pneumoniae ST258 clone", Antimicrob Agents Chemother, 56, pp.3444~3447 (2012)
- Zarfel G, "Emergence of New Delhi metallo-β-lactamase, Austria", Emerg Infect Dis, 17, pp.129~130 (2011)
- Ellington MJ, "Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases", J Antimicrob Chemother, 59, pp.321~322 (2007)
- Aubert D, "Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of β-lactam resistance genes", J Bacteriol, 188, pp.6506~6514 (2006)
- Yum JH, "Molecular characterization of metallob-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea : identification of two new integrons carrying the blaVIM-2 gene cassettes", J Antimicrob Chemother, 49, pp.837~840 (2002)
- Hopkins KL, "Evaluation of the NG-Test Carba 5multiplex immunochromatographic assay for the detection of KPC, OXA-48-like, NDM, VIM and IMP carbapenemases", J Antimicrob Chemother, 73, pp.3523~3526 (2018)
- Volland H, "Improvement of the immunochromatographic NG-Test Carba 5 assay for the detection of IMP variants previously undetected", Antimicrob Agents Chemother, 64, pp.e01940~19 (2020)
- Khalifa HO, "Comparative evaluation of five assays for detection of carbapenemases with a proposed scheme for their precise application", J Mol Diagn, 22, pp.1129~1138 (2020)
- Giordano L, "Simplified testing method for direct detection of carbapenemase-producing organisms from positive blood cultures using the NG-Test Carba 5 assay", Antimicrob Agents Chemother, 63, pp.e00550~19 (2019)
- Jenkins S, "Evaluation of NG-Test Carba 5 for rapid phenotypic detection and differentiation of five common carbapenemase families : results of a multicenter clinical evaluation", J Clin Microbiol, 58, pp.e00344~20 (2020)
- Takissian J, "NG-Test Carba 5 for rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures", Antimicrob Agents Chemother, 63, pp.e00011~19 (2019)
- Go E, "Distributions of carbapenem-resistant Enterobacteriaceae (CRE) in Korea", Public Health Wkly Rep, 13, pp.3348~3355 (2020)
- 송원근, "Rapid Identification of OXA-48-like, KPC, NDM, and VIM Carbapenemase-Producing Enterobacteriaceae From Culture: Evaluation of the RESIST-4 O.K.N.V. Multiplex Lateral Flow Assay", Annals of Laboratory Medicine, 40(3), pp.259~263 (2020), 대한진단검사의학회[DOI]
- Bogaerts P, "Comparison of two multiplex immunochromatographic assays for the rapid detection of major carbapenemases in Enterobacterales", J Antimicrob Chemother, 75, pp.1491~1494 (2020)
- Ratnayake L, "An optimized algorithm with improved turnaround time for detection of carbapenemase-producing Enterobacterales using the NG Test Carba 5 in a routine laboratory", J Med Microbiol, 69, pp.228~232 (2020)
- Lee E, "Analysis of carbapenemase-producing Enterobacteriaceae(CPE)surveillance results for 2017 in Korea : comparison with the surveillance results of the previous 5 years(2012-2016)", Public Health Wkly Rep, 11, pp.1586~1594 (2018)
